Stay updated on Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.3.2 and removal of Revision: v3.3.1, an administrative update to the version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:27:51.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision entries were updated: added v3.3.1 and removed v3.2.0 from the history.
    Difference
    0.1%
    Check dated 2025-11-24T11:06:45.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The notice about government funding and potential data delays was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-17T06:10:56.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Version 23 (2025-06-25) was added, updating Study Status, Eligibility, Arms and Interventions, and Outcome Measures in the study record. This addition indicates ongoing updates to the trial's registration information.
    Difference
    0.1%
    Check dated 2025-11-03T00:48:57.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    11%
    Check dated 2025-10-05T08:03:04.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.3%
    Check dated 2025-09-28T02:57:43.000Z thumbnail image

Stay in the know with updates to Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.